High Purity Dxm Hydrobromide Powder Dxm HCl
Human Anatomical Model,Anatomical Human Brain Model,Gender Neutral Torso Anatomy Model,Lumbar Disc Herniation Demonstration Model Yinchuan Erxin Technology Co., LTD , https://www.exmedmodel.com
Trade name:
Benylin DM, Mucinex DM, Robitussin, NyQuil, Dimetapp, Vicks, Coricidin, Delsym, Camydex-20, TheraFlu, Cheracol D,DexAlone,Duract.
Molecular Formula: C18H26BrNO (or "C18H25NO · HBr")
Molecular weight 352.31
Boiling point 486.1 ºC
Flash point 247.8 ºC
Vapor Pressure 2.92E-10mmHg at 25 ° C
Traits: White powder
Function category: This product is antitussive non-prescription drugs
Indications
For dry cough, including upper respiratory tract infections (such as colds and pharyngitis), bronchitis and other coughs.
Dosage
oral. Adults: 1 to 2 tablets, 3-4 times a day.
Adverse reactions
Visible dizziness, headache, lethargy, irritability, belching, lack of appetite, constipation, nausea, skin allergies, etc., but does not affect the efficacy. After stopping the above reaction can disappear. Overdose can cause confusion, bronchospasm, respiratory depression.
Precautions
1. Medication for 7 days, the symptoms did not ease, consult a physician or pharmacist. 2. Asthma patients, patients with sputum, liver and kidney dysfunction with caution. 3. Pregnant women with caution. 4 children please consult a physician or pharmacist. 5. During the medication may not drive machines, cars, boats, engaged in aerial work, mechanical operations and the operation of precision instruments. 6. disabled on the drug allergy, allergies used with caution. 7. It is forbidden to use the medicine when its traits change. 8. Keep this medicine out of the reach of children. 9. Children must be used under adult supervision. 10. If other medicines are being used, consult a physician or pharmacist before using this medicine.
medicine interactions
1. Not with monoamine oxidase inhibitors and antidepressants and use. 2. The drug should not be used with ethanol and other central Nervous System inhibitory drugs, because it can enhance the central inhibitory effect. 3. Drug interactions may occur if used with other medications. Consult physician or pharmacist for details.
Taboo
Women within 3Â months of pregnancy, disabled persons with history of mental illness and lactating women.
Patients taking a monoamine oxidase inhibitor for less than two weeks were disabled.
Storage: shading, sealed and preserved.
Â
L-Triiodothyronine(T3)
(CAS: 55-06-1)
L-Thyroxine (T4)
(CAS: 51-48-9)
Â
Â
Â
Â
Dutasteride
(CAS: 164656-23-9)
Finasteride
(CAS: 98319-26-7)
Acetildenafil
(CAS: 831217-01-7)
Yohimbine HCl
(CAS: 65-19-0)
Procaina HCl
(CAS: 51-05-8)
Lidocaina HCl
(CAS: 73-78-9)
Benzocaina
(CAS: 94-09-7)
Tetracaina HCl
(CAS: 136-47-0)
Pramiracetam
(CAS: 68497-62-1)
Alpha-Arbutin
(CAS: 84380-01-8)
Tretinoin
(CAS: 302-79-4)
Isotretinoin
(CAS: 4759-48-2)
2,5-dimethoxyphenethylamine
(CAS: 3600-86-0)
1,3-Dimethylamylamine hydrochloride
(CAS: 13803-74-2)
Pramipexole
(CAS: 191217-81-9)
Deflazacort
(CAS: 14484-47-0)
Rimonabant HCl
(CAS: 158681-13-1)
Laxogenin
(CAS: 1177-71-5)
Trade name:
Benylin DM, Mucinex DM, Robitussin, NyQuil, Dimetapp, Vicks, Coricidin, Delsym, Camydex-20, TheraFlu, Cheracol D,DexAlone,Duract.
Molecular Formula: C18H26BrNO (or "C18H25NO · HBr")
Molecular weight 352.31
Boiling point 486.1 ºC
Flash point 247.8 ºC
Vapor Pressure 2.92E-10mmHg at 25 ° C
Traits: White powder
Function category: This product is antitussive non-prescription drugs
Indications
For dry cough, including upper respiratory tract infections (such as colds and pharyngitis), bronchitis and other coughs.
Dosage
oral. Adults: 1 to 2 tablets, 3-4 times a day.
Adverse reactions
Visible dizziness, headache, lethargy, irritability, belching, lack of appetite, constipation, nausea, skin allergies, etc., but does not affect the efficacy. After stopping the above reaction can disappear. Overdose can cause confusion, bronchospasm, respiratory depression.
Precautions
1. Medication for 7 days, the symptoms did not ease, consult a physician or pharmacist. 2. Asthma patients, patients with sputum, liver and kidney dysfunction with caution. 3. Pregnant women with caution. 4 children please consult a physician or pharmacist. 5. During the medication may not drive machines, cars, boats, engaged in aerial work, mechanical operations and the operation of precision instruments. 6. disabled on the drug allergy, allergies used with caution. 7. It is forbidden to use the medicine when its traits change. 8. Keep this medicine out of the reach of children. 9. Children must be used under adult supervision. 10. If other medicines are being used, consult a physician or pharmacist before using this medicine.
medicine interactions
1. Not with monoamine oxidase inhibitors and antidepressants and use. 2. The drug should not be used with ethanol and other central nervous system inhibitory drugs, because it can enhance the central inhibitory effect. 3. Drug interactions may occur if used with other medications. Consult physician or pharmacist for details.
Taboo
Women within 3Â months of pregnancy, disabled persons with history of mental illness and lactating women.
Patients taking a monoamine oxidase inhibitor for less than two weeks were disabled.
Storage: shading, sealed and preserved.
Â
L-Triiodothyronine(T3)
(CAS: 55-06-1)
L-Thyroxine (T4)
(CAS: 51-48-9)
Â
Â
Â
Â
Dutasteride
(CAS: 164656-23-9)
Finasteride
(CAS: 98319-26-7)
Acetildenafil
(CAS: 831217-01-7)
Yohimbine HCl
(CAS: 65-19-0)
Procaina HCl
(CAS: 51-05-8)
Lidocaina HCl
(CAS: 73-78-9)
Benzocaina
(CAS: 94-09-7)
Tetracaina HCl
(CAS: 136-47-0)
Pramiracetam
(CAS: 68497-62-1)
Alpha-Arbutin
(CAS: 84380-01-8)
Tretinoin
(CAS: 302-79-4)
Isotretinoin
(CAS: 4759-48-2)
2,5-dimethoxyphenethylamine
(CAS: 3600-86-0)
1,3-Dimethylamylamine hydrochloride
(CAS: 13803-74-2)
Pramipexole
(CAS: 191217-81-9)
Deflazacort
(CAS: 14484-47-0)
Rimonabant HCl
(CAS: 158681-13-1)
Laxogenin
(CAS: 1177-71-5)